https://www.bioworld.com/articles/713328-ono-pharmaceutical-identifies-new-ep3-receptor-agonists?v=preview
Ono Pharmaceutical identifies new EP3 receptor agonists | BioWorld
Ono Pharmaceutical Co. Ltd. has patented tricyclic prostaglandin E2 receptor EP3 subtype (PTGER3; EP3) agonists potentially useful for the treatment of renal...
ono pharmaceuticalreceptor agonistsnewbioworld
https://www.ono-pharma.com/en/news?article_id=216&years_id=366&news_id=All&category=year
2025. | News | ONO PHARMACEUTICAL CO., LTD.
ono pharmaceuticalnewscoltd
https://www.ono-pharma.com/en/ir/esg.html
ESG Initiatives | Investors | ONO PHARMACEUTICAL CO., LTD.
esg initiativesono pharmaceuticalinvestorscoltd
https://health.economictimes.indiatimes.com/tag/ono+pharmaceutical+co
Ono pharmaceutical co - Latest ono pharmaceutical co , Information & Updates - Health -ET...
ETHealthworld.com brings latest ono pharmaceutical co news, views and updates from all top sources for the Indian Health industry.
ono pharmaceuticallatest informationcoupdateshealth
https://www.ono-pharma.com/en/news?article_id=216&years_id=311&news_id=All&category=year
2000. | News | ONO PHARMACEUTICAL CO., LTD.
ono pharmaceuticalnewscoltd
https://synapse.net/medicine/902/
PROEMEND for I.V. Infusion 150mg : Ono Pharmaceutical Co., Ltd.| synapse
Information on PROEMEND for I.V. Infusion 150mg from Ono Pharmaceutical Co., Ltd. online, Ministry of Health and Welfare Code is 2391405D1020, packaging is 1...
ono pharmaceuticalvinfusion
https://synapse.net/medicine/870/
ONOACT for I.V. Infusion 50mg : Ono Pharmaceutical Co., Ltd.| synapse
Information on ONOACT for I.V. Infusion 50mg from Ono Pharmaceutical Co., Ltd. online, Ministry of Health and Welfare Code is 2123404D1033, packaging is 1 vial...
ono pharmaceuticalvinfusion
https://www.ono-pharma.com/en/news?article_id=216&years_id=266&news_id=All&category=year
2009. | News | ONO PHARMACEUTICAL CO., LTD.
ono pharmaceuticalnewscoltd
https://www.massbio.org/news/member-news/win-a-labcentral-golden-ticket-form-ono-pharmaceutical/
Win a LabCentral Golden Ticket form Ono Pharmaceutical! - MassBio
golden ticketono pharmaceuticalwinformmassbio
https://www.ono-pharma.com/en/news?article_id=216&years_id=346&news_id=All&category=year
2023. | News | ONO PHARMACEUTICAL CO., LTD.
ono pharmaceuticalnewscoltd
https://www.bioworld.com/articles/713328-ono-pharmaceutical-identifies-new-ep3-receptor-agonists?v=preview
Ono Pharmaceutical identifies new EP3 receptor agonists | BioWorld
Ono Pharmaceutical Co. Ltd. has patented tricyclic prostaglandin E2 receptor EP3 subtype (PTGER3; EP3) agonists potentially useful for the treatment of renal...
ono pharmaceuticalreceptor agonistsnewbioworld
https://www.ono-pharma.com/en/news?article_id=216&years_id=366&news_id=All&category=year
2025. | News | ONO PHARMACEUTICAL CO., LTD.
ono pharmaceuticalnewscoltd
https://www.ono-pharma.com/en/ir/esg.html
ESG Initiatives | Investors | ONO PHARMACEUTICAL CO., LTD.
esg initiativesono pharmaceuticalinvestorscoltd